लोड हो रहा है...

Current advancements in promoting remyelination in multiple sclerosis

Current multiple sclerosis (MS) therapies are effective in reducing the rate of relapse, short-term measures of disability, and MRI measures of inflammation, whereas in progressive/degenerative disease phases, these medications are of little or no benefit. Therefore, the development of new therapies...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Mult Scler
मुख्य लेखकों: Kremer, David, Akkermann, Rainer, Küry, Patrick, Dutta, Ranjan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2018
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389436/
https://ncbi.nlm.nih.gov/pubmed/30270725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458518800827
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!